The 5-HT1A/1B-receptor agonist eltoprazine increases both catecholamine release in the prefrontal cortex and dopamine release in the nucleus accumbens and decreases motivation for reward and “waiting” impulsivity, but increases “stopping” impulsivity

Autor: Korte, S. Mechiel, Prins, Jolanda, Van den Bergh, Filip S., Oosting, Ronald S., Dupree, Rudy, Korte-Bouws, Gerdien A.H., Westphal, Koen G.C., Olivier, Berend, Denys, Damiaan A., Garland, Alexis, Güntürkün, Onur
Zdroj: In European Journal of Pharmacology 5 January 2017 794:257-269
Databáze: ScienceDirect